Centruroides (scorpion) Immune F(ab')2 (equine) Injectable Solution

Brand(s)
Anascorp
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Rare Disease Therapeutics, Inc. (2013-12-04)
Oldest Current Product
2011-08-03
License(s)
BLA
RxNORM
INJECTABLE SOLUTION\CENTRUROIDES (SCORPION) IMMUNE F(AB')2 (EQUINE)
SPL Active
INTRAVENOUS\INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION\SCORPION (CENTRUROIDES) IMMUNE FAB2 ANTIVENIN (EQUINE)
SPL Moiety
INTRAVENOUS\INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION\SCORPION (CENTRUROIDES) IMMUNE FAB2 ANTIVENIN (EQUINE)

product(s) by strength(s)

centruroides (scorpion) immune f(ab')2 (equine) 24 mg/ml injectable solution

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1666210150AnascorpBLARare Disease Therapeutics, Inc.2011-08-03SCORPION (CENTRUROIDES) IMMUNE FAB2 ANTIVENIN (EQUINE)INTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION1253355cb65048-a30c-48e5-8bc8-897983d08068

application(s)

#idtitleapprovedtradenamesfda division
1125335Centruroides (Scorpion) Immune F(ab')2 (Equine) Injection Application2011-08-03AnascorpCBER

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
15cb65048-a30c-48e5-8bc8-897983d08068 (view SPL)These highlights do not include all the information needed to use Anascorp safely and effectively. See full prescribing information for Anascorp. Anascorp Centruroides (Scorpion) Immune F(ab')2 (Equine) Injection Lyophilized for Solution For Intravenous Use Only Initial U.S. Approval: 2011prescriptionHuman PrescriptionRare Disease Therapeutics, Inc.manufacture2013-12-043666210150

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII